01 / DESIGN
What was studied?
Seventy-two participants with major depressive disorder completed a reward-learning task before and after a randomized sixteen-week study.
02 / FINDINGS
What did the researchers report?
Computational analysis found changes in choosing higher-expected-reward options and repeating previous choices in the semaglutide group.
03 / LIMITS
How should it be interpreted?
Task behavior is not the same endpoint as depression remission or improved daily functioning. This secondary analysis does not establish a psychiatric indication or support self-directed use.
Voltera Peptide editorial reading note. Based on the linked source record. Methods and corrections.